The initiative aligns with unprecedented shifts in U.S. defense priorities. For the 2027 fiscal year, the proposed U.S. military budget allocates over $74 billion to drones and counter-drone systems, part of a $1.5 trillion total funding package. This historic investment marks the largest commitment to drone warfare in U.S. history, signaling a permanent move toward manned-unmanned teaming in combat and logistics.

TOMI is positioning itself as the primary biosafety provider for this technological evolution. By partnering with a U.S.-based lithium-ion battery provider, TOMI is developing a specialized autonomous product line designed to neutralize biological and chemical threats in environments where human presence is high-risk or impossible. This expansion builds upon TOMI's foundational history of decontaminating unmanned aircraft, now scaling to meet the critical need for automated, verifiable biosafety across every major transit vector.

Beyond aerospace, these automated systems are being designed for naval fleets, cruise ships, and shipping containers to ensure decontaminated international trade. On the ground, TOMI is developing rapid-deployment solutions for high-speed rail, autonomous trucking fleets, and public transit hubs, alongside specialized drone-mounted iHP systems for the rapid neutralization of high-risk outdoor or large-scale indoor environments.

"Our expansion into autonomous technology represents a pivotal shift in how we approach high-stakes decontamination across the entire transport spectrum," said Dr. Halden Shane, CEO of TOMI Environmental Solutions. "Whether it is a naval vessel, a commercial airliner, or a lunar habitat, this advancement ensures that even the most complex environments can be neutralized rapidly and precisely. This allows our partners in the military and public health sectors to focus on their mission while our technology handles the risk."

By investing capital into verifiable, automated biosafety, TOMI is addressing a critical gap in the modern defense and infrastructure landscape. As global sectors prioritize the reduction of human exposure to hazardous agents, TOMI's scalable, instant-deployment solutions ensure the Company remains at the forefront of the world's most complex biological and chemical challenges.